Paracelsian Inc (PRLN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Paracelsian Inc (PRLN)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: chris labastill who wrote (1716)	2/14/1997 7:31:00 AM
From: WWS	of 4342

Christine, Could you clarify one statistic from your posting to us about the S/B meeting, please? If PRLN projects a share of market in Year One of 3.8% of all US AIDS patients for AndroVir, then by my calculations this would amount to approximately 38,000 patients (3.8% of the 1 million w/AIDS in this country). At a sales price of $720/year/patient, this would amount to annual US sales of about $27 million for AndroVir, which is more than the figure of $2.4 million that you mentioned. Once again, let me say thanks for taking your time to keep us all informed. Bill.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next